2 news items
HC Wainwright & Co. Reiterates Buy on Cocrystal Pharma, Maintains $10 Price Target
COCP
4 Apr 24
HC Wainwright & Co. reiterates Cocrystal Pharma (NASDAQ:COCP) with a Buy and maintains $10 price target.
Cocrystal Pharma Discusses Antiviral Therapeutics' Clinical Development and 2024 Value Catalysts in New CEO Video Interview on Planet MicroCap
COCP
5 Mar 24
company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses (including
- Prev
- 1
- Next